These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 739602)

  • 21. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Detection of HLA-Bw4 antibody in an alloimmunized patient with nonlymphocytic leukemia].
    Ryo R; Hashimoto M; Saigo K; Nakaya Y; Yamaguchi N
    Rinsho Ketsueki; 1985 Dec; 26(12):1974-8. PubMed ID: 3834162
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of 4 crossmatching methods for predicting the success of platelet transfusion].
    Santoso S; Kiefel V; Kühn J; Mueller-Eckhardt G; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():153-6. PubMed ID: 1703818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alloreactive lymphocytotoxic antibodies in patients with multiple transfusions and on a chronic hemodialysis program].
    Lazić M
    Srp Arh Celok Lek; 1985; 113(11-12):973-81. PubMed ID: 3835725
    [No Abstract]   [Full Text] [Related]  

  • 25. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
    Menitove JE; Duquesnoy RJ
    Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bone marrow transplantation in aplastic anemia with refractory states in platelet transfusions].
    Kodoh H; Horiuchi N; Nakada H; Kumakawa J; Shirafuji N
    Rinsho Ketsueki; 1986 Jul; 27(7):1278-81. PubMed ID: 3537368
    [No Abstract]   [Full Text] [Related]  

  • 27. Heterogeneity of antibody response to human platelet transfusion.
    Wu KK; Thompson JS; Koepke JA; Hoak JC; Flink R
    J Clin Invest; 1976 Aug; 58(2):432-8. PubMed ID: 956376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of kidney transplantation in highly sensitized patients after donor-specific blood transfusion.
    Takahashi K; Yagisawa T; Tanabe I; Teraoka S; Hayasaka Y; Yasuo M; Fuchinoue S; Honda H; Toma H; Agishi T
    Transplant Proc; 1987 Oct; 19(5):3655-60. PubMed ID: 2960043
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of platelet alloimmunity with a platelet-associated IgG assay.
    Myers TJ; Kim BK; Steiner M; Bishop J; Baldini MG
    J Lab Clin Med; 1981 Jun; 97(6):854-63. PubMed ID: 7014743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histocompatibility testing in clinical renal transplantation.
    Braun WE
    Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
    [No Abstract]   [Full Text] [Related]  

  • 31. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
    Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
    Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unrecognized causes of platelet transfusion failure in the presence of anti-HL-A antibodies.
    Hattersley PG
    West J Med; 1977 Apr; 126(4):263-6. PubMed ID: 855318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alloimmunization following platelet transfusions in patients with acute nonlymphocytic leukemia.
    Nozaki H; Shimizu M; Komatsuda M; Watanabe K; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1986 Aug; 11(3):201-4. PubMed ID: 3475819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of HLA alloimmunization due to platelet transfusion].
    van Marwijk Kooy M; Brand A; Sintnicolaas K; van Prooijen HC
    Ned Tijdschr Geneeskd; 1988 Apr; 132(17):758-61. PubMed ID: 3374659
    [No Abstract]   [Full Text] [Related]  

  • 35. Earlier detection of HLA alloimmunization in platelet transfusion refractoriness by flow cytometric analysis.
    Sato S; Sakurai T; Yamamoto Y; Maekawa I; Ikeda H
    Transfusion; 2005 Aug; 45(8):1399-401. PubMed ID: 16078932
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of lymphocytotoxicity and staph-protein A assays in platelet donor selection.
    Bonacossa IA; Perchotte MR; Olchowecki JK; Schroeder ML
    Curr Stud Hematol Blood Transfus; 1986; (52):58-64. PubMed ID: 3698686
    [No Abstract]   [Full Text] [Related]  

  • 37. [Thrombocyte substitution in acute leukemia. Effect of histocompatibility on the clinical efficacy].
    Kubel M; Freistedt B; Hammer P; Thierbach V; Helbig W; Haustein B; Schultze W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):355-64. PubMed ID: 6179839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Selection of HLA compatible donors for patients with HLA antibodies].
    Májský A; Korínková P; Kubícková Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):937-43. PubMed ID: 2419224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing platelet survival during antilymphocyte globulin treatment.
    Gratama JW; Brand A; Jansen J; Zwaan FE; Valentijn RM; Eernisse JG
    Br J Haematol; 1984 May; 57(1):5-15. PubMed ID: 6722037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Platelet and granulocyte transfusion in hematology].
    Ouellet P
    Union Med Can; 1983 May; 112(5):457-60. PubMed ID: 6879858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.